share_log

采纳股份(301122.SZ):子公司部分产品通过美国FDA审核

Adopted shares (301122.SZ): Some of the subsidiary's products have passed the US FDA review

Gelonghui Finance ·  Mar 8 05:20

On March 8, Ge Longhui Co., Ltd. (301122.SZ) announced that Jiangsu Adona Medical Technology Co., Ltd., a wholly-owned subsidiary, recently received a notice from the US Food and Drug Administration to adopt medical safety slide blood collection needle products that have passed the US FDA's review and officially obtained permission to enter the US market. Up to now, the company and its subsidiaries have 29 FDA-registered products.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment